We are a clinical-stage biopharmaceutical company with a ‘Nature to Medicine’ strategy and a focus on mental health. We are utilising the latest technological developments in clinical research and drug design to bring to market a new generation of medicines based on natural compounds with unique and promising therapeutic properties. We are dedicated to improving patients’ lives.
on October 5, 2021
Comments are closed.